US Generic Injectable Market Size, Demand, Share, Growth Drivers, Companies and Forecast 2023-2028
IMARC Group has recently released a new research study titled “ US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. How big is the US generic injectables market? The US generic injectables market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.7 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028. US Generic Injectable Market Report | IMARC Group Industry Overview: A generic injectable is a bioequivalent version of a branded injectable medication, typically offered at a lower cost. These injectables contain the same active ingredients, potency, and dosage form as their branded counterparts, but they may differ in inactive ingredients such as preservatives or stabilizers. Generic ...